Evidence map›Paper›PMID 26091063›Full record

ArticleOrganic letters2015

Enantioselective Hydroformylation of 1-Alkenes with Commercial Ph-BPE Ligand.

Zhiyong Yu, Meredith S Eno, Alexandra H Annis, James P Morken

Abstract read
In one paragraph

Article in Organic letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhiyong YuDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States.
Meredith S EnoDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States.
Alexandra H AnnisDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States.
James P MorkenDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States.

Funding

DEVELOPMENT AND STUDY OF ENZYME FUNCTIONAL MIMICSR01GM059417 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MORKEN, JAMES PATRICK · 1999 to 2017
$4.1M
Steroselective Reductive Condensation ReactionsR01GM064451 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI MORKEN, JAMES PATRICK · 2002 to 2016
$3.2M
Development of Catalytic Conjunctive Coupling ReactionsR01GM118641 · NIGMS · BOSTON COLLEGE · PI MORKEN, JAMES PATRICK · 2017 to 2018
$635k
NIGMS NIH HHS GM 059417NIGMS NIH HHS GM 064451NIGMS NIH HHS R01 GM059417NIGMS NIH HHS R01 GM064451NIGMS NIH HHS R01 GM118641
6 · The paper itself

Abstract

A rhodium complex, in conjunction with commercially available Ph-BPE ligand, catalyzes the branch-selective asymmetric hydroformylation of 1-alkenes and rapidly generates α-chiral aldehydes. A wide range of terminal olefins including 1-dodecene were examined, and all delivered high enantioselectivity (up to 98:2 er) as well as good branch:linear ratios (up to 15:1).

Indexed as

AldehydesAlkenesCatalysisCombinatorial Chemistry TechniquesLigandsMolecular StructureRhodiumStereoisomerismAldehydesAlkenesLigandsRhodium

Identifiers

PMID26091063
PMCPMC4608024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.